Remote Funded Healthcare Sector Momentum Trader

What You'll Trade

Large pharma (JNJ, MRK, PFE, LLY) for stable trend trades and option liquidity, large biotech (AMGN, GILD, REGN) for fundamental-driven positioning, mid-cap biotech for catalyst trades around clinical data and FDA decisions, medical device names (ISRG, MDT) for steady momentum, and payers (UNH, ELV) for policy-driven moves.

Day-to-Day

• Morning: review the FDA calendar, clinical readout schedule, and overnight political/policy news affecting payers
• Track relative strength of healthcare sub-sectors versus XLV and the broader market
• Position into and out of catalyst events with defined risk — biotech binary events require options structures, not naked equity
• Manage steady-trend positions in large-caps with trailing stops

Risk Profile

Healthcare carries binary catalyst risk in biotech (one FDA decision moves a stock 40%), regulatory and political risk in payers and large pharma, and patent-cliff timing risk. Maverick limits biotech catalyst exposure to defined-risk structures and caps total sector concentration.

Who Succeeds in This Role

• Traders with a science or medical background — or who have done the work to understand it
• People who can read a clinical trial press release and assess the actual signal
• Candidates who already follow the FDA PDUFA calendar and major medical conferences
• Traders who can size catalyst trades for binary outcomes, not normal-distribution outcomes

Why This Role Exists at Maverick

Healthcare rewards domain expertise more than almost any other sector — the difference between a real clinical signal and noise isn't visible from price action alone. Maverick funds specialists who bring genuine sector knowledge, not generalists picking up healthcare names off a momentum screen.

Open Locations

This role is open to US-based applicants. Browse sector momentum trader (healthcare) positions by metro: